112 related articles for article (PubMed ID: 16840184)
21. Delayed-onset grade 4 neutropenia associated with rituximab therapy in a patient with lymphoma: case report and literature review.
Motl SE; Baskin RC
Pharmacotherapy; 2005 Aug; 25(8):1151-5. PubMed ID: 16207108
[TBL] [Abstract][Full Text] [Related]
22. Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections.
Tesfa D; Ajeganova S; Hägglund H; Sander B; Fadeel B; Hafström I; Palmblad J
Arthritis Rheum; 2011 Aug; 63(8):2209-14. PubMed ID: 21560117
[TBL] [Abstract][Full Text] [Related]
23. Rituximab-induced vasculitis.
Dereure O; Navarro R; Rossi JF; Guilhou JJ
Dermatology; 2001; 203(1):83-4. PubMed ID: 11549810
[No Abstract] [Full Text] [Related]
24. [Proteins in haematology].
Clarenbach RE; Mey U
Ther Umsch; 2011 Nov; 68(11):610-7. PubMed ID: 22045523
[TBL] [Abstract][Full Text] [Related]
25. [Cryptococcus neoformans meningoencephalitis in a patient treated with rituximab].
Sánchez-Ojanguren J; Isern-Segura I; Chico-Chumillas C; Javaloyas-de-Morlius M
Med Clin (Barc); 2009 Jun; 133(4):157-8. PubMed ID: 19268330
[No Abstract] [Full Text] [Related]
26. Organizing pneumonia associated with rituximab: Challenges raised by establishing causality.
Lioté H
Joint Bone Spine; 2008 May; 75(3):260-2. PubMed ID: 18424160
[No Abstract] [Full Text] [Related]
27. FDA: Increased HBV reactivation risk with ofatumumab or rituximab.
Mitka M
JAMA; 2013 Oct; 310(16):1664. PubMed ID: 24150447
[No Abstract] [Full Text] [Related]
28. Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment.
Davis TA; Grillo-López AJ; White CA; McLaughlin P; Czuczman MS; Link BK; Maloney DG; Weaver RL; Rosenberg J; Levy R
J Clin Oncol; 2000 Sep; 18(17):3135-43. PubMed ID: 10963642
[TBL] [Abstract][Full Text] [Related]
29. Rituximab-related late-onset neutropenia in a patient with severe rheumatoid arthritis.
Marotte H; Paintaud G; Watier H; Miossec P
Ann Rheum Dis; 2008 Jun; 67(6):893-4. PubMed ID: 18474658
[No Abstract] [Full Text] [Related]
30. Rituximab-induced acute thrombocytopenia: a report of two cases.
Otrock ZK; Mahfouz RA; Oghlakian GO; Salem ZM; Bazarbachi A
Haematologica; 2005 Nov; 90 Suppl():ECR23. PubMed ID: 16266914
[TBL] [Abstract][Full Text] [Related]
31. Rituximab-induced tumor cell agglutination.
Sivakumaran M
Blood; 2002 Oct; 100(7):2672; author reply 2673. PubMed ID: 12360978
[No Abstract] [Full Text] [Related]
32. Acute tumor lysis syndrome induced by rituximab in diffuse large B-cell lymphoma.
Jabr FI
Int J Hematol; 2005 Nov; 82(4):312-4. PubMed ID: 16298821
[TBL] [Abstract][Full Text] [Related]
33. Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis.
Aksoy S; Dizdar O; Hayran M; Harputluoğlu H
Leuk Lymphoma; 2009 Mar; 50(3):357-65. PubMed ID: 19263297
[TBL] [Abstract][Full Text] [Related]
34. Late-onset neutropenia following rituximab treatment in patients with autoimmune diseases.
Rios-Fernández R; Gutierrez-Salmerón MT; Callejas-Rubio JL; Fernández-Pugnaire M; Ortego-Centeno N
Br J Dermatol; 2007 Dec; 157(6):1271-3. PubMed ID: 17916218
[No Abstract] [Full Text] [Related]
35. Community-based phase II trial of PCR for CLL/SLL patients.
Kay NE; Shanafelt TD; Byrd JC; Grever MR
Cancer Biother Radiopharm; 2007 Oct; 22(5):713-4; author reply 715-7. PubMed ID: 17979574
[No Abstract] [Full Text] [Related]
36. New therapies, new concerns: rituximab-associated lung injury.
Lands LC
Pediatr Nephrol; 2010 Jun; 25(6):1001-3. PubMed ID: 20195643
[No Abstract] [Full Text] [Related]
37. Recurrent fevers, cough, and pulmonary opacities in a middle-aged man.
Bauer PR; Zent CS; Aubry MC; Ryu JH
Chest; 2010 Jun; 137(6):1465-9. PubMed ID: 20525658
[No Abstract] [Full Text] [Related]
38. Rituximab-induced hypersensitivity pneumonitis.
Tonelli AR; Lottenberg R; Allan RW; Sriram PS
Respiration; 2009; 78(2):225-9. PubMed ID: 18843175
[TBL] [Abstract][Full Text] [Related]
39. Rituximab-induced immunodysregulatory ileocolitis in a patient with follicular lymphoma.
Blombery P; Prince HM; Levinson M; Pianko S; Maxwell E; Bhathal P
J Clin Oncol; 2011 Feb; 29(5):e110-2. PubMed ID: 21098319
[No Abstract] [Full Text] [Related]
40. Long-lasting hypogammaglobulinemia following rituximab administration for Epstein-Barr virus-related post-transplant lymphoproliferative disease preemptive therapy.
Castagnola E; Dallorso S; Faraci M; Morreale G; Di Martino D; Cristina E; Scarso L; Lanino E
J Hematother Stem Cell Res; 2003 Feb; 12(1):9-10. PubMed ID: 12662431
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
